Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P4RA
|
|||
| Former ID |
DIB016800
|
|||
| Drug Name |
Repifermin
|
|||
| Synonyms |
FGF 10; FGF-10, HGS; Fibroblast growth factor-10, HGS; KGF-2, HGS; KGF-2D33, HGS; Keratinocyte growth factor-2, HGS; S69-S208, HGS
Click to Show/Hide
|
|||
| Indication | Oral mucositis [ICD-11: DA01.11; ICD-10: K12.3; ICD-9: 528] | Discontinued in Phase 2 | [1] | |
| Company |
Human Genome Sciences Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009979) | |||
| REF 2 | Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther. 2003 Jun 1;17(11):1355-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.